EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blue Biotechnology Startups in Bangladesh: An Empirical Evidence on Opportunities Barriers, and Pathways Forward

M. R. Washikur, Sanjana Tarannum, Mohammad Nazir Hossain

Journal of Entrepreneurship & Business Strategies · 16.06.2026 · 2 (1) · 72-82

DOI: 10.54536/jebs.v2i1.6957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Entrepreneurship & Business Strategies, online erschienen am 16.06.2026. Verfasst von M. R. Washikur und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global blue biotechnology sector, projected to exceed $10 trillion by 2030 through marine-derived pharmaceuticals, nutraceuticals, and sustainable aquaculture innovations, represents an unprecedented economic frontier that Bangladesh, endowed with 118,813 km² of exclusive economic zone and unparalleled Bay of Bengal biodiversity, remains uniquely positioned to capture through strategic startup ecosystem development. This pioneering study employs a quantitative cross-sectional survey (N=223) targeting Bangladesh’s blue biotechnology stakeholders, revealing a significant paradox: 93.3% exhibit entrepreneurial fervor, yet 75.3% perceive an investment crisis as the most existential operational threat, while 96.9% affirm the sector’s viability, despite 59.2% acknowledging knowledge deficits. Chi-square analyses (p < .001) reveal age-stratified challenge perceptions, with youth decrying government support voids, mid-career professionals’ infrastructure chasms, and gender-differentiated opportunity lenses. Males prioritize seafood demand (43.4%), while females focus on raw material abundance (28.1%). Marine natural products (39.9%) and aquaculture biotech (31.4%) emerge as consensus research priorities; however, a 40-point intention-investment chasm (93% vs. 53%) signals a capital ecosystem failure. Universal endorsement (100%) of university-industry symbiosis demands immediate institutionalization. This research fills the academic void on blue biotech entrepreneurship in developing countries, delivering battle-tested policy instruments: patient-capital venture funds, shared marine biobanks, formalized tech-transfer pipelines, and hybrid business models that fuse domestic aquaculture scaling with global pharma licensing. Bangladesh confronts a binary future: squander a trillion-dollar marine inheritance through inaction, or architect a blue biotech supernova catalyzing 21st-century economic transcendence. The empirical clarion call: convert 93% entrepreneurial fire into a $10B+ GDP alchemy through the ruthless execution of the knowledge-capital-infrastructure triad.

Zitieren

APA

Washikur, M. R., Tarannum, S., & Hossain, M. N. (2026). Blue Biotechnology Startups in Bangladesh: An Empirical Evidence on Opportunities Barriers, and Pathways Forward. Journal of Entrepreneurship & Business Strategies, 2(1), 72-82. https://doi.org/10.54536/jebs.v2i1.6957

Vancouver

Washikur MR, Tarannum S, Hossain MN. Blue Biotechnology Startups in Bangladesh: An Empirical Evidence on Opportunities Barriers, and Pathways Forward. Journal of Entrepreneurship & Business Strategies. 2026;2(1):72-82. doi:10.54536/jebs.v2i1.6957

BibTeX
@article{Washikur2026,
  author = {Washikur, M. R. and Tarannum, Sanjana and Hossain, Mohammad Nazir},
  title = {Blue Biotechnology Startups in Bangladesh: An Empirical Evidence on Opportunities Barriers, and Pathways Forward},
  journal = {Journal of Entrepreneurship & Business Strategies},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {72--82},
  doi = {10.54536/jebs.v2i1.6957}
}
Kostenlos starten →